FDA approval boosts Elon Musk-owned Neuralink's valuation to $5 billion
Shortpedia
Content Team
Image Credit: telegraph india
The valuation of Elon Musk's brain implant start-up Neuralink has gone up from around $2 billion in 2021 to $5 billion right now based on privately executed stock trades, according to Reuters. With bullish investors by his side and the approval of human trials for the revolutionary chip, the company is expected to reach greater heights in the coming years.
